Latest Articles
Trans woman heavily criticised after being appointed to represent an endometriosis charity resigns 'in best interests' of the cause - Daily Mail
Trans woman heavily criticised after being appointed to represent an endometriosis charity resigns 'in best interests' of the cause Daily Mail
Published: April 16, 2026, 11:03 a.m.
Medical and Surgical Management of Endometriosis: A Narrative Review of Clinical Outcomes - Cureus
Medical and Surgical Management of Endometriosis: A Narrative Review of Clinical Outcomes Cureus
Published: April 16, 2026, 10:49 a.m.
Lena Dunham on endometriosis pain leading to hysterectomy - Stylist
Lena Dunham on endometriosis pain leading to hysterectomy Stylist
Published: April 16, 2026, 10:37 a.m.
Trial Marks “Major Step in Progress in Endometrial Cancer Research” - Oncology News Central
Trial Marks “Major Step in Progress in Endometrial Cancer Research” Oncology News Central
Published: April 16, 2026, 10:14 a.m.
Endometrial Cancer Staging Updates Reflect Molecular Profiling - Cleveland Clinic
Endometrial Cancer Staging Updates Reflect Molecular Profiling Cleveland Clinic
Published: April 16, 2026, 5:42 a.m.
Buds of hope: Medicinal cannabis may offer pain relief for some with endometriosis - NZ Herald
Buds of hope: Medicinal cannabis may offer pain relief for some with endometriosis NZ Herald
Published: April 16, 2026, 1:50 a.m.
Endometriosis Advocate Jenneh Rishe Dies of Sudden Blood Clot in Her Lungs - People.com
Endometriosis Advocate Jenneh Rishe Dies of Sudden Blood Clot in Her Lungs People.com
Published: April 15, 2026, 10:36 p.m.
BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer - BioPharm International
BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer BioPharm International
Published: April 15, 2026, 10:02 p.m.
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target - TipRanks
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target TipRanks
Published: April 15, 2026, 9:42 p.m.
'My endometriosis was ignored for 18 years - the NHS change has come too late for me, but not for you' - Manchester Evening News
'My endometriosis was ignored for 18 years - the NHS change has come too late for me, but not for you' Manchester Evening News
Published: April 15, 2026, 6:24 p.m.
Link copied to clipboard!